Supplements

Ceriva 30 ct. (RS)

Overview

Ceriva scores 72/100 for effectiveness due to solid meta-analytic support for Huperzine A in AD cognition (e.g., Yang 2013 meta-analysis of 20 RCTs showed cognitive benefits, PMID 24086396; Ha 2014 meta, PMID 24639880) at matching 200 mcg dose, but limited small RCTs for PRP (e.g., Bilikiewicz 2002 double-blind, PMID 10608295) and no combo or general cognition studies. Safety at 84 reflects rare mild sides and interactions but appropriate warnings. Quality 85 from reputable brand's purity testin

Key strengths

Our analysis

Good (77/100) - Ceriva scores 72/100 for effectiveness due to solid meta-analytic support for Huperzine A in AD cognition (e.g., Yang 2013 meta-analysis of 20 RCTs showed cognitive benefits, PMID 24086396; Ha 2014 meta, PMID 24639880) at matching 200 mcg dose, but limited small RCTs for PRP (e.g., Bilikiewicz 2002 double-blind, PMID 10608295) and no combo or general cognition studies. Safety at 84 reflects rare mild sides and interactions but appropriate warnings. Quality 85 from reputable brand's purity testing claims, though lacking public certs. Weighted: 72*0.6 + 84*0.25 + 85*0.15 = 77. Overall good for targeted ACh support in supervised use.

Frequently asked questions

Is Ceriva 30 ct. (RS) worth buying?
Ceriva 30 ct. (RS) has a Verify Influencers trust score of 68/100 based on ingredient quality, clinical evidence, and third-party testing.
What is the trust score for Ceriva 30 ct. (RS)?
Ceriva 30 ct. (RS) scored 68 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.

Browse all scored products · How products are scored